We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.23B
AUM Growth
+$348M
Cap. Flow
+$172M
Cap. Flow %
7.72%
Top 10 Hldgs %
19.36%
Holding
1,755
New
109
Increased
939
Reduced
649
Closed
58

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$14.5M
2
AMGN icon
Amgen
AMGN
+$11.6M
3
ABBV icon
AbbVie
ABBV
+$10.2M
4
CELG
Celgene Corp
CELG
+$8.88M
5
BIIB icon
Biogen
BIIB
+$7.99M

Sector Composition

Rank Sector Weight
1 Healthcare 24.35%
2 Technology 12.32%
3 Financials 9.33%
4 Industrials 8.44%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQIX icon
76
Equinix
EQIX
$107B
$3.98M 0.18%
22,421
+4,779
+27% +$794K
CBST
77
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$3.96M 0.18%
57,570
+15,701
+38% +$1.02M
SPG icon
78
Simon Property Group
SPG
$74.5B
$3.91M 0.18%
27,298
-1,489
-5% -$215K
DUK icon
79
Duke Energy
DUK
$102B
$3.88M 0.17%
56,232
+753
+1% +$52.7K
LLY icon
80
Eli Lilly
LLY
$1.07T
$3.78M 0.17%
74,185
+4,052
+6% +$203K
PEP icon
81
PepsiCo
PEP
$186B
$3.69M 0.17%
44,509
+1,019
+2% +$84.6K
HAL icon
82
Halliburton
HAL
$27.9B
$3.68M 0.17%
72,574
+2,625
+4% +$136K
ADP icon
83
Automatic Data Processing
ADP
$100B
$3.67M 0.16%
51,671
+7,390
+17% +$497K
ORCL icon
84
Oracle
ORCL
$331B
$3.6M 0.16%
94,184
+13,824
+17% +$475K
CCI icon
85
Crown Castle
CCI
$32.7B
$3.59M 0.16%
48,938
+1,073
+2% +$79.4K
CVS icon
86
CVS Health
CVS
$137B
$3.55M 0.16%
49,608
+5,620
+13% +$361K
HSBC icon
87
HSBC
HSBC
$355B
$3.52M 0.16%
74,104
+4,755
+7% +$225K
USB icon
88
US Bancorp
USB
$99.6B
$3.47M 0.16%
85,947
-5,838
-6% -$224K
DTV
89
DELISTED
DIRECTV COM STK (DE)
DTV
$3.47M 0.16%
50,233
+5,154
+11% +$330K
VIAB
90
DELISTED
Viacom Inc. Class B
VIAB
$3.45M 0.15%
39,541
+3,231
+9% +$267K
ALKS icon
91
Alkermes
ALKS
$8.82B
$3.36M 0.15%
82,723
+75,143
+991% +$2.77M
RDS.A
92
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$3.35M 0.15%
46,950
+4,178
+10% +$281K
PX
93
DELISTED
Praxair Inc
PX
$3.25M 0.15%
25,003
+1,912
+8% +$238K
AXP icon
94
American Express
AXP
$223B
$3.21M 0.14%
35,434
+970
+3% +$79.7K
GS icon
95
Goldman Sachs
GS
$313B
$3.17M 0.14%
17,901
-1,251
-7% -$206K
BBL
96
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$3.15M 0.14%
50,706
+16,111
+47% +$974K
LNKD
97
DELISTED
LinkedIn Corporation
LNKD
$3.07M 0.14%
14,141
+5,776
+69% +$1.31M
D icon
98
Dominion Energy
D
$62.5B
$3.06M 0.14%
47,250
+1,718
+4% +$111K
IONS icon
99
Ionis Pharmaceuticals
IONS
$9.35B
$3.02M 0.14%
75,738
+15,378
+25% +$548K
LYB icon
100
LyondellBasell Industries
LYB
$19.5B
$3.01M 0.13%
37,497
+1,937
+5% +$148K

Similar funds

Profund Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Profund Advisors held 1,755 positions worth $2.23B, up 18% from $1.88B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Profund Advisors deployed $172M of net new capital in Q4 2013, opening 109 new positions and adding to 939 existing holdings. Its largest new stake was Ambev: 287,712 shares worth $2.12M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was ARM HOLDINGS PLC ADS, an estimated $2.18M trimmed.

  • Profund Advisors's largest Q4 2013 buy was Ambev: 287,712 shares worth $2.12M.
  • Profund Advisors added most to Gilead Sciences in Q4 2013, an estimated $14.5M increase.
  • Profund Advisors's biggest Q4 2013 reduction was ARM HOLDINGS PLC ADS, cutting an estimated $2.18M.
  • Profund Advisors fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $2.1M.
  • Profund Advisors's ten largest holdings make up 19% of its $2.23B portfolio in Q4 2013.
  • Profund Advisors opened 109 new positions and closed 58 in Q4 2013.
  • Profund Advisors's portfolio value rose 18% quarter-over-quarter to $2.23B.

Based on Profund Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.